openPR Logo
Press release

Antithrombin Market Trends and Therapeutic Applications By 2031 | Most Leading Companies - CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc

04-30-2025 10:51 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Antithrombin Market

Antithrombin Market

The Global Antithrombin Market reached USD 545 million in 2022 and is projected to witness lucrative growth by reaching up to USD 775.7 million by 2030. The Global Antithrombin Market is expected to exhibit a CAGR of 4.6% during the forecast period 2024-2031

Antithrombin Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/antithrombin-market?kb

Antithrombin is a natural anticoagulant protein found in blood plasma that helps regulate blood clotting by inhibiting thrombin and other clotting factors such as factor Xa. It plays a crucial role in preventing abnormal blood clots and maintaining the balance between bleeding and coagulation.

List of the Key Players in the Antithrombin Market:

CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc, Siemens AG, Thermo Fisher Scientific, Lee Biosolutions Inc., BDI Pharma, among others.

Research Process:

Both primary and secondary data sources have been used in the global Antithrombin Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/antithrombin-market?kb

Segment Covered in the Antithrombin Market:

By Usage: Therapeutics, Diagnostics, Research, Other

By Type: Anticoagulant, Antiplatelet, Thrombolytic Drug

By Route of Administration: Oral, Parenteral

By Source: Human, Recombinant Goat milk, Others

Regional Analysis for Antithrombin Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antithrombin-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Antithrombin market?

➠ Who are the leading manufacturers in the global Antithrombin industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Antithrombin industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Antithrombin market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antithrombin Market Trends and Therapeutic Applications By 2031 | Most Leading Companies - CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc here

News-ID: 3994294 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Nanoencapsulated Food Additives Market 2025: Industry Developments, Future Growth, Share & Industry Insights | GF Fermentech, Frutarom Industries Ltd., AQUANOVA AG
Nanoencapsulated Food Additives Market 2025: Industry Developments, Future Growt …
"Nanoencapsulated Food Additives Market size reached US$ 188.21 million in 2024 and is expected to reach US$ 326.29 million by 2032, growing with a CAGR of 7.12% during the forecast period 2025-2032. " As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/nanoencapsulated-food-additives-market?sg Industry developments & market outlook ✅ 26 May 2025 - Market report: the Nanoencapsulated Food Additives market was reported (DataM Intelligence) with
United States Attention Deficit Hyperactivity Disorder (ADHD) Stimulants: Methylphenidate & Amphetamine Market Share By 2025-2033 | Top Most Keyplayers - Pfizer Inc., Takeda Pharmaceutical, Novartis AG, Eli Lilly and Company, Lupin
United States Attention Deficit Hyperactivity Disorder (ADHD) Stimulants: Methyl …
Market Size and Forecast: Attention Deficit Hyperactivity Disorder (ADHD) Market size reached US$ 16.23 billion in 2024 and is expected to reach US$ 27.04 billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033. According to DataM Intelligence Comprehensive Report has released its latest report on the "Attention Deficit Hyperactivity Disorder Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional
United States Solar PV Panels Market 2025: Industry Developments, Future Growth, Share & Industry Insights | ABB, Hanwha Q CELL, Huawei, JA Solar, LONGI, Mitsubishi Electric
United States Solar PV Panels Market 2025: Industry Developments, Future Growth, …
"Solar PV Panels Market Size was US$180.29 billion in 2024 and is expected to reach US$330.50 billion by 2032, growing with a CAGR of 7.87% during the forecast period 2025-2032" As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/solar-pv-panels-market?sg Industry developments 2025: ✅ [2025-05-07] Tandem-cell R&D (silicon-perovskite stacks) continued to make headlines in 2025: papers and industry reports flagged tandem approaches as the most
United States Hydrogenated Styrene Block Copolymers Market 2025: Industry Developments, Future Growth, Share & Industry Insights
United States Hydrogenated Styrene Block Copolymers Market 2025: Industry Develo …
"Global Hydrogenated Styrene Block Copolymers Market is expected to grow at a CAGR of 6% during the forecast period 2024-2031." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/hydrogenated-styrene-block-copolymers-market?sg USA - Recent Industry Developments 2025: ✅ 28 Jan 2025 - Teknor Apex showcased new TPE innovations (applications relevant to healthcare and medical tubing that overlap with SEBS/HSBC use cases) at MD&M West (product /

All 5 Releases


More Releases for Antithrombin

Antithrombin Market - From Safety to Success: Antithrombin Solutions for Effecti …
Newark, New Castle, USA: The "Antithrombin Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Antithrombin Market: https://www.growthplusreports.com/report/antithrombin-market/7760 This latest report researches the industry structure, sales, revenue, price and
Antithrombin Market Size, Share & Growth Report 2030
The global Antithrombin market accounted for USD 543.0 Million in 2020 and is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028. Antithrombin is a protein present in the blood stream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to
Antithrombin Market Report Up to 2031
Visiongain has published a new report on Antithrombin Market Report to 2031. Market is segmented by source (Human, Goat milk, others), By Application (Therapeutics, Research, Diagnostic, Others), By Type (Anticoagulants, Antiplatele, Thrombolytic Drugs). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antithrombin Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/antithrombin-market/#download_sampe_div The study covers detailed and insightful chapters
Antithrombin Market Analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI
Antithrombin Market - Size, Share, Outlook, 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI
Antithrombin Market analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI